Assess the efficacy of deep convolutional neural networks (DCNNs) in detection of critical enteric feeding tube malpositions on radiographs. 5475 de-identified HIPAA compliant frontal view chest and abdominal radiographs were obtained, consisting of 174 x-rays of bronchial insertions and 5301 non-critical radiographs, including normal course, normal chest, and normal abdominal x-rays. The ground-truth classification for enteric feeding tube placement was performed by two board-certified radiologists. Untrained and pretrained deep convolutional neural network models for Inception V3, ResNet50, and DenseNet 121 were each employed. The radiographs were fed into each deep convolutional neural network, which included untrained and pretrained models. The Tensorflow framework was used for Inception V3, ResNet50, and DenseNet. Images were split into training (4745), validation (630), and test (100). Both real-time and preprocessing image augmentation strategies were performed. Receiver operating characteristic (ROC) and area under the curve (AUC) on the test data were used to assess the models. Statistical differences among the AUCs were obtained. p < 0.05 was considered statistically significant. The pretrained Inception V3, which had an AUC of 0.87 (95 CI; 0.80–0.94), performed statistically significantly better ( p < .001) than the untrained Inception V3, with an AUC of 0.60 (95 CI; 0.52–0.68). The pretrained Inception V3 also had the highest AUC overall, as compared with ResNet50 and DenseNet121, with AUC values ranging from 0.82 to 0.85. Each pretrained network outperformed its untrained counterpart. ( p < 0.05). Deep learning demonstrates promise in differentiating critical vs. non-critical placement with an AUC of 0.87. Pretrained networks outperformed untrained ones in all cases. DCNNs may allow for more rapid identification and communication of critical feeding tube malpositions.

To investigate whether bipolar androgen therapy (BAT), involving rapid cyclic administration of high-dose testosterone, as a novel treatment for metastatic castration-resistant prostate cancer (mCRPC) promotes improvements in body composition and associated improvements in lipid profiles and quality of life. Patients and MethodsMen from two completed trials with computed tomography imaging at baseline and after three cycles of BAT were included. Cross-sectional areas of psoas muscle, visceral and subcutaneous fat were measured at the L3 vertebral level. Functional Assessment of Chronic Illness Therapy -Fatigue questionnaire and 36-item short-form health survey were used to assess quality of life. ResultsThe 60 included patients lost a mean (SD) of 7.8 (8.2)% of subcutaneous fat, 9.8 (18.2)% of visceral fat, and gained 12.2 (6.7)% muscle mass. Changes in subcutaneous and visceral fat were positively correlated with each other (Spearman's correlation coefficient 0.58, 95% confidence interval 0.35-0.71) independent of the effects of age, body mass index, and duration of androgen-deprivation therapy. Energy, physical function, and measures of limitations due to physical health were all significantly improved at 3 months. The improvements in body composition were not correlated with decreases in lipid levels or observed improvements in quality of life. ConclusionsIn the present study, BAT was associated with significant improvements in body composition, lipid parameters, and quality of life. This has promising implications for the long-term health of men with mCRPC.

Jugular foramen paragangliomas (JFP) are benign tumors of neural crest origin that are located along the temporal bone in the region of the jugular bulb and middle ear. The optimal management of these lesions includes surgical excision with or without preoperative embolization as well as stereotactic radiotherapy. The use of preoperative embolization in the treatment of JFP has shown great promise to bridge patients to surgery by diminishing complication rates and decreasing intraoperative bleeding. We present three successful polyvinyl alcohol (PVA) particle embolizations of patients presenting with symptomatic JFPs. All patients recovered completely in the short term with no bleeding during or after resection of paragangliomas and they were discharged free of their presenting symptoms. Early clinical and imaging diagnosis followed by adequate treatment including preoperative transcatheter particle embolization and surgical or radiosurgical interventions can lead to excellent outcomes.

No abstract

The obesity epidemic is a growing public health concern that has a severe effect on the health care system with significant morbidity, mortality, and cost. Treatment options for obesity include lifestyle modifications, pharmacotherapy, and bariatric surgery. Newer, less-invasive therapies including endoscopic bariatric procedures have been developed in recent years to fill the treatment gap that exists between noninvasive approaches and surgery. Bariatric artery embolization (BAE) is a novel minimally invasive endovascular procedure that has been developed to treat obesity. Recent evidence has suggested that bariatric embolization is well tolerated and can induce clinically significant weight loss through a hormonally mediated mechanism. This article will review existing preclinical and clinical data, and explore future directions of the endovascular treatment of obesity.